Results 31 to 40 of about 1,797 (187)

Application of a microdosed cocktail of 3 oral factor Xa inhibitors to study drug–drug interactions with different perpetrator drugs

open access: yesBritish Journal of Clinical Pharmacology, Volume 86, Issue 8, Page 1632-1641, August 2020., 2020
Aims Using 3 different perpetrators the impact of voriconazole, cobicistat and rifampicin (single dose), we evaluated the suitability of a microdose cocktail of factor Xa inhibitors (FXaI; rivaroxaban, apixaban and edoxaban; 100 μg in total) to study drug–drug interactions.
Gerd Mikus   +5 more
wiley   +1 more source

Long‐term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

open access: yesPediatric Pulmonology, Volume 55, Issue 7, Page 1725-1735, July 2020., 2020
Abstract Rationale Bronchiolitis obliterans syndrome (BOS) is a severe, chronic inflammation of the airways leading to an obstruction of the bronchioles. So far, there are only a few studies looking at the long‐term development of pulmonary impairment in children with BOS.
Sophie Walther   +10 more
wiley   +1 more source

Situation of anti-fungal resistance of species of the genus Candida in Peru

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2018
We are currently witnessing a constant and ongoing change of the epidemiological pictures of yeast resistance to antifungal agents, related to the type of host, etiology of the disease, the microorganism involved, and its mechanisms of resistance.
Susana Zurita Macalupú
doaj   +1 more source

ESPONDILODISCITE POR ASPERGILLUS FUMIGATUS EM PACIENTE VIVENDO COM HIV/AIDS EM SUPRESSÃO VIRAL: RELATO DE CASO

open access: yesBrazilian Journal of Infectious Diseases, 2022
Introdução: A espondilodiscite por Aspergillus spp. é uma forma rara de aspergilose extrapulmonar que ocorre predominantemente em pacientes imunocomprometidos.
Júlia Lustosa Martinelli   +3 more
doaj   +1 more source

Validación de un método para determinar la concentración sérica de voriconazol por HPLC/UV [PDF]

open access: yes, 2022
RESUMEN Antecedentes: El incremento de infecciones fúngicas invasivas ha incrementado el uso de voriconazol como profilaxis y tratamiento, siendo necesario monitorizar sus concentraciones séricas.
Sánchez-de Castro,M   +7 more
core   +1 more source

Fusariose em paciente imunocomprometido: sucesso terapêutico com voriconazol Fusariosis in an immunocompromised patient: therapeutic success with voriconazole

open access: yesAnais Brasileiros de Dermatologia, 2008
A infecção por Fusarium solani é afecção fúngica potencialmente grave em pacientes imunocomprometidos, sobretudo naqueles portadores de neoplasias hematológicas. A mortalidade é alta,sendo limitadas as opções terapêuticas devido às condições da imunidade
Thaís Prota Hussein Pincelli   +4 more
doaj   +1 more source

In silico, in vitro und in vivo Charakterisierung der Hemmung ausgewählter Fremdstoff-metabolisierender Enzyme des Menschen durch Voriconazol [PDF]

open access: yes, 2016
Zur Präzisierung des inhibitorischen Potentials des etablierten Antimykotikums Voriconazol auf ausgewählte, den Midazolam-Metabolismus betreffende Enzyme wurden Inhibitionsstudien in vitro und in vivo durchgeführt, um Interaktionen unter Beteiligung von ...
Junge, Lisa
core   +1 more source

Cuerpo extraño vegetal intrabronquial con colonización por Aspergillus [PDF]

open access: yesRevista SOCAMPAR, 2019
La aspiración de cuerpo extraño en la vía aérea es poco frecuente en adultos. Es poco probable que se relate el episodio de atragantamiento espontáneamente como antecedente claro y suele pasar inadvertido.
Arroyo-Cózar M,   +2 more
doaj  

FUSARIOSE EM PACIENTE COM LINFOMA LINFOBLÁSTICO T - RELATO DO CASO

open access: yesHematology, Transfusion and Cell Therapy, 2023
Objetivo: Relatar um caso de infecção fúngica invasiva por fusarium em paciente com Linfoma Linfoblástico T. Relato de caso: P. F. M. C., 38 anos, sexo feminino, deu entrada em nosso serviço em fevereiro de 2021 com diagnóstico de Linfoma Linfoblástico T
FC Domingos   +8 more
doaj   +1 more source

PS1214 INFECTIOUS COMPLICATIONS FOLLOWING ARI‐0001 CELL (A3B1:CD8:4–1BB:CD3Z CART19) TREATMENT IN ADULT AND PEDIATRIC PATIENTS WITH CD19+ RELAPSED / REFRACTORY MALIGNANCIES

open access: yesHemaSphere, Volume 3, Issue S1, Page 553-554, June 2019., 2019
Background: Several chimeric antigen receptor products targeting CD19 are either approved or in development for the treatment of acute lymphoblastic leukemia (ALL) and non‐Hodgkin's lymphoma (NHL). Nevertheless, information on infections and immune impairment caused by this procedure (lymphodepletion chemotherapy, neutropenia, B‐cell aplasia and ...
V. Ortiz‐Maldonado   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy